RAP 0.00% 20.5¢ raptor resources limited

Ann: At-Home Obstructive Sleep Apnoea Study Update, page-201

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,848 Posts.
    lightbulb Created with Sketch. 1446
    DROWZLE is a prescription, Class II medical device that consists of stand-alone smartphone-based software (operating on Apple iPhone 7, 8, or X model using iOS v10.0 or later) that records and analyzes respiratory patterns during sleep for the purpose of in-home screening for obstructive sleep apnea (OSA).

    https://www.prnewswire.com/news-releases/resonea-obtains-fda-clearance-for-smartphone-based-in-home-screening-for-obstructive-sleep-apnea-300891093.html

    I gave a thumbs up for the answer Zodiac, happy that you responded. A quick check on net has the above paragraph. How does that fit?
    Last edited by trousergecko: 02/10/19
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.